April 16, 2023•
Merck has agreed to acquire Prometheus Biosciences for about $10.8 billion to bolster the company’s presence in immunology, the companies said on Sunday.
Last modified: April 16, 2023
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Δ
This site uses Akismet to reduce spam. Learn how your comment data is processed.
